Endoglin (ENG) Peptide
ENG
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN939431
Quick Overview for Endoglin (ENG) Peptide (ABIN939431)
Target
Endoglin (ENG)
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Peptide Type
- Synthetic
-
Sequence
- ILEVHVLFLE FPTGPSQLEL TLQASKQNGT WPREVLLVLS VNSSVFLHLQ
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ENG antibody,
Alternative Names: Endoglin control peptide, Endoglin antibody Blocking Peptide, Anti-Endoglin Blocking Peptide, Osler-Rendu-Weber Syndrome 1 Blocking Peptide, ENG Blocking Peptide -
Purification
- Unpurified neat serum.
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- Endoglin (ENG)
-
Background
- Endoglin is a homodimeric transmembrane glycoprotein highly expressed by endothelial cells. It is a component of the transforming growth factor beta receptor complex since it binds TGFB1 and TGFB3 with high affinity. Mutations in the endoglin gene produce hereditary hemorrhagic telangiectasia.
-
Molecular Weight
- 68 kDa
Target
-
You are here:
